导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.40% | 467/1050 |
| 近一周 | -0.71% | 86/1104 |
| 近一月 | -3.27% | 383/1102 |
| 近一季 | -9.38% | 629/1092 |
| 近半年 | -5.30% | 622/1070 |
| 近一年 | 6.89% | 423/1018 |
| 近两年 | 33.80% | 647/926 |
| 近三年 | 15.23% | 546/834 |
| 成立以来 | 62.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.27% 408/1070 |
20.80% 374/1101 |
- - |
- - |
| 2025 | 18.39% 689/1065 |
-3.16% 960/1014 |
1.55% 548/1038 |
19.74% 616/1050 |
0.54% 427/1065 |
| 2024 | 2.10% 523/1011 |
1.61% 227/960 |
4.12% 131/983 |
1.68% 945/991 |
-5.09% 674/1011 |
| 2023 | -20.09% 672/952 |
-5.28% 800/880 |
-1.70% 286/895 |
-9.06% 554/915 |
-5.63% 571/952 |
| 2022 | -20.36% 337/867 |
-20.31% 530/773 |
8.82% 308/806 |
-3.96% 49/845 |
-4.37% 618/867 |
| 2021 | -6.39% 437/740 |
-9.89% 488/580 |
4.32% 479/659 |
-6.95% 410/704 |
7.03% 148/740 |
| 2020 | 55.56% 214/554 |
-0.22% 165/419 |
21.03% 266/466 |
17.01% 103/517 |
10.10% 355/554 |
| 2019 | 45.54% 180/410 |
26.09% 628/1149 |
-3.19% 594/1231 |
8.90% 132/390 |
9.48% 175/410 |
| 2018 | -25.81% 158/349 |
- - |
- - |
- - |
-10.07% 300/1080 |
| 2017 | 30.80% 36/285 |
- - |
- - |
- - |
- - |
| 2016 | -7.42% 57/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 光大保德信国企改革股票A VS. 东吴新产业精选股票A(580008) |